| Autor: |
Dunne MW; Pfizer Global Research & Development, New London, Connecticut 06320, USA. michael_w_dunne@groton.pfizer.com, Khurana C, Mohs AA, Rodriguez A, Arrieta A, McLinn S, Krogstad JA, Blatter M, Schwartz R, Vargas SL, Emparanza P, Fernandez P, Gooch WM 3rd, Aspin M, Podgore J, Roine I, Blumer JL, Ehrlich GD, Chow J |
| Jazyk: |
angličtina |
| Zdroj: |
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2003 Aug; Vol. 47 (8), pp. 2663-5. |
| DOI: |
10.1128/AAC.47.8.2663-2665.2003 |
| Abstrakt: |
Children with acute otitis media underwent tympanocentesis and were given a single dose of 30 mg of azithromycin/kg of body weight. At day 28, the overall clinical cure rate was 206 of 242 (85%). Clinical cure rates for patients infected with Streptococcus pneumoniae (67 of 76; 88%) and Haemophilus influenzae (28 of 44; 64%) were consistent with historical rates for the 5-day dosing regimen. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
